ERBB2 and neoplasm: For example, CD3 T cells are the main recognition unit in recognizing antigens; previous studies had shown that CD3 x anti-HER2 bispecific antibodies increased the cytotoxic activity of HER2-positive tumor cells and had significant antitumour effects (Han et al., 2014; Ren et al., 2012).